ORC6 and central nervous system cancer: After removing missing prognosis data, samples were divided equally based on the median ORC6 expression level (151 ORC6-high and 150 ORC6-low), an elevation in ORC6 expression correlates with poor overall survival among glioma patients (Fig. 2B).